Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Aspirin
100%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
100%
Prospective Cohort Study
100%
Breast Cancer Mortality
100%
Hormone Receptor-positive
100%
Relative Risk
100%
Postmenopausal Breast Cancer
100%
Confidence Interval
87%
Tumor
37%
Low Risk
37%
Breast Cancer
25%
Aspirin Use
25%
Estrogen Receptor Status
25%
Progesterone Receptor Expression
25%
Drug Use
12%
Postmenopausal Women
12%
Protective Effect
12%
ER +
12%
Breast Cancer Risk
12%
Tumor Microenvironment
12%
Estrogen Signaling
12%
Population-based Cohort
12%
Low Incidence
12%
Self-administered Questionnaire
12%
Frequency of Use
12%
Inverse Association
12%
Non-associated
12%
Cox Proportional Hazards Model
12%
Frequent Use
12%
Aromatase Activity
12%
Breast Cancer Cases
12%
Breast Cancer Risk Factors
12%
Non-aspirin Non-steroidal Anti-inflammatory Drugs
12%
SEER Cancer Registry
12%
Progesterone Signaling
12%
Multiple Breast Cancer
12%
Cellular Pathways
12%
Pharmacology, Toxicology and Pharmaceutical Science
Non-Steroidal Anti-Inflammatory Drug
100%
Prospective Cohort Study
100%
Acetylsalicylic Acid
100%
Breast Cancer
100%
Cancer Incidence
100%
Hormone Receptor
100%
Estrogen Receptor
18%
Neoplasm
18%
Progesterone Receptor
18%
Cancer Registry
9%
Aromatase
9%
Progesterone
9%
Tumor Microenvironment
9%
Biochemistry, Genetics and Molecular Biology
Prospective Cohort Study
100%
Cancer Incidence
100%
Hormone Receptor
100%
Anti-Inflammatory
100%
Estrogen Receptor
33%
Progesterone Receptor
33%
Independent Pathway
16%
Cancer Registry
16%
Postmenopause
16%
Aromatase
16%
Progesterone
16%